Recently, as a non-invasive approach to diagnosing preeclampsia, ongoing attempts have been made to measure various biomarkers such as sFlt-1, PlGF, and soluble endoglin (sEng) with maternal urine samples17–19. This evidence concerns the gene PGF and preeclampsia.